Chinese-made Sinopharm Covid-19 coronavirus vaccine (Photo by ISHARA S. KODIKARA / AFP)
6,938 public, private and civil organisations registered for China’s state-owned Sinopharm COVID-19 vaccine for more than 3.18 million people on Monday, the first day of online registration.
Sinopharm will be Thailand’s first vaccine not to be provided by the Thai government for the masses and is being procured by Chulabhorn Royal Academy (CRA), to help the government in its efforts to procure more vaccines for the country.
The first batch of one million doses will arrive in Thailand on Sunday (June 20th), with about 5-6 million more scheduled to arrive in the next few months. Inoculations will begin on June 25th, according to the CRA.
Sinopharm is an inactivated virus type of vaccine, suitable for individuals who are 18 or older. Two doses are required, with the second shot taken 3-4 weeks after the first.
On May 28th, the Chinese made vaccine became the fifth to be approved by Thailand’s Food and Drug Administration (TFDA). Other vaccines approved include Sinovac, also from China, the UK’s AstraZeneca and the US’s Johnson & Johnson and Moderna.
Only Sinovac and AstraZeneca are currently being administered in Thailand.